Advanced Medical Therapies
Physician-guided use of the newest medicines for diabetes and weight loss.
Mounjaro and Ozempic treatment in India should always be physician-guided. At EDFC in Surat, GLP-1 and dual-agonist medicines such as tirzepatide and semaglutide are used under medical supervision — with candidacy, dosing, side-effect management and monitoring handled by the clinic's medical team.
What are GLP-1, Mounjaro and Ozempic therapies?
GLP-1 based medicines work by lowering blood sugar and reducing appetite, which supports weight loss. Semaglutide (sold as Ozempic and Wegovy) and tirzepatide (Mounjaro, a dual-agonist) are among the most effective options and are now an established part of diabetes and obesity care worldwide.
These medicines are powerful but are not for everyone. The right candidate, dose and monitoring matter — which is why, at Elegance Diabetic Foot & Ulcer Clinic (EDFC), they are prescribed and supervised by the clinic's medical team rather than used unsupervised. India's diabetes burden of around 101 million people (ICMR-INDIAB, 2023) has made these therapies increasingly common, making safe, guided use more important than ever.
Therapy is offered at our Surat and Vizianagaram branches with structured follow-up.
Who is suitable for these therapies?
These medicines may be considered if you:
- Have type 2 diabetes that is not well controlled on current treatment
- Are living with obesity or significant excess weight
- Have not reached your goals with diet and lifestyle alone
- Are willing to be monitored and reviewed regularly
- Do not have conditions that make these medicines unsuitable
When to see a doctor in India: never start or source these medicines without medical assessment — suitability, dosing and side effects must be checked by a doctor first.
Why choose EDFC for advanced diabetes therapy in India
- Supervised, safe use: candidacy, dosing, side effects and response are all managed by the clinic's medical team
- Combined with the cause: medicines are paired with nutrition and weight-loss support, not used in isolation
- Founder-led standards: EDFC was founded by Dr. Ashutosh Shah (M.S., M.Ch.); therapies follow the same supervised standard
- Honest guidance: we explain benefits, side effects and limits clearly, with no hype or guarantees